SCHEMBL5469536

SCHEMBL5469536

Cn1ccn(CCO)c1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.40
▸ ADORA2B P29275 1/20 0.40
▸ PDE4A P27815 1/20 0.35
▸ PDE4B Q07343 1/20 0.35
▸ PDE4C Q08493 1/20 0.35
▸ PDE4D Q08499 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.33
▸ KDM6A O15550 1/20 0.33
▸ KDM4A O75164 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ KDM5C P41229 1/20 0.33
▸ KDM2B Q8NHM5 1/20 0.33
▸ DOHH Q9BU89 1/20 0.33
▸ KDM2A Q9Y2K7 1/20 0.33
▸ CCNE1 P24864 1/20 0.32
▸ CDK2 P24941 1/20 0.32
▸ CA1 P00915 2/20 0.32
▸ CA2 P00918 2/20 0.32
▸ HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4622919 0.85 LMNA (0.40) LMNAADORA2BPDE4APDE4BPDE4C
SCHEMBL10566488 0.84 — —
SCHEMBL15906247 0.79 TYR (0.37) ADORA2BPDE4APDE4BPDE4CPDE4D
SCHEMBL14257134 0.76 — —
SCHEMBL18686731 0.76 ALDH1A1 (0.42) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL4842898 0.74 — —
SCHEMBL30526236 0.74 LMNA (0.38) LMNAADORA2BPDE4APDE4BPDE4C
SCHEMBL14652120 0.74 HTT (0.39) HSD17B10ALDH1A1
SCHEMBL27298478 0.74 ALDH1A1 (0.42) LMNAADORA2BPDE4APDE4BPDE4C
SCHEMBL3590708 0.74 ALDH1A1 (0.43) LMNAADORA2BKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118354759-A Compositions comprising 2' -deoxycytidine analogs and their use for treating sickle cell disease, thalassemia and cancer 阿基拉比奥有限公司 2024-07-16 — — CN disclosed
CN-116209439-A Substituted N- (2, 6-dioxopiperidin-3-yl) -1, 3-dioxoisoindolin-5-yl) arylsulfonamide analogs as cereblon modulators 圣裘德儿童研究医院有限公司 2023-06-02 — — CN disclosed
US-20070190143-A1 Disintegrating tablets comprising licarb azepine NOVARTIS AG (CH) 2007-08-16 — — US disclosed
EP-1729737-A1 DISINTEGRATING TABLETS COMPRISING LICARBAZEPINE Novartis AG (CH) 2006-12-13 — — EP disclosed
WO-2005092290-A1 DISINTEGRATING TABLETS COMPRISING LICARBAZEPINE NOVARTIS AG (CH) 2005-10-06 — — WO disclosed
CN-1037346-C Therapeutic agents BOOTS CO LTD (GB) 1998-02-11 — — CN disclosed
Send feedback